Literature DB >> 15255079

Therapeutic options in systemic AL amyloidosis.

I I van Gameren1, H Lokhorst, B P C Hazenberg, E Vellenga.   

Abstract

Systemic amyloid light chain (AL) amyloidosis is a severe disease with unfavourable prognosis. Since the late 1970s different therapeutic modalities in AL amyloidosis have been investigated, trying to prolong survival. This review deals with the therapeutic modalities in AL amyloidosis to date, and highlights future perspectives.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15255079

Source DB:  PubMed          Journal:  Neth J Med        ISSN： 0300-2977            Impact factor:   1.422


  2 in total

1.  Magnetic resonance imaging of a temporal lobe cerebral amyloidoma.

Authors:  Jack Ogilvie; Raymond Zhao; Sandra Camelo-Piragua; Mohannad Ibrahim; Remy Lobo; John Kim
Journal:  Radiol Case Rep       Date:  2022-06-08

2.  Primary cerebral low-grade B-cell lymphoma, monoclonal immunoglobulin deposition disease, cerebral light chain deposition disease and "aggregoma": an update on classification and diagnosis.

Authors:  Marco Skardelly; Georgios Pantazis; Sotirios Bisdas; Guenther C Feigl; Martin U Schuhmann; Marcos S Tatagiba; Rainer Ritz
Journal:  BMC Neurol       Date:  2013-08-15       Impact factor: 2.474
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.